Holderness Investments Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Buy
1,702
+408
+32% +$414K 0.31% 75
2025
Q4
$1.39M Buy
1,294
+374
+41% +$358K 0.28% 72
2025
Q3
$702K Sell
920
-467
-34% -$348K 0.14% 127
2025
Q2
$1.08M Sell
1,387
-947
-41% -$736K 0.23% 91
2025
Q1
$1.93M Buy
2,334
+12
+0.5% +$9.98K 0.45% 58
2024
Q4
$1.79M Buy
2,322
+21
+0.9% +$17.4K 0.4% 62
2024
Q3
$2.04M Buy
2,301
+40
+2% +$36K 0.45% 61
2024
Q2
$2.05M Buy
2,261
+76
+3% +$60.8K 0.48% 52
2024
Q1
$1.7M Buy
2,185
+1,040
+91% +$740K 0.42% 62
2023
Q4
$667K Buy
1,145
+40
+4% +$23.3K 0.18% 126
2023
Q3
$594K Buy
1,105
+462
+72% +$238K 0.23% 104
2023
Q2
$302K Buy
643
+8
+1% +$3.35K 0.11% 159
2023
Q1
$218K Buy
635
+22
+4% +$7.42K 0.09% 186
2022
Q4
$224K Sell
613
-107
-15% -$37.9K 0.1% 174
2022
Q3
$233K Sell
720
-10
-1% -$3.17K 0.11% 175
2022
Q2
$237K Sell
730
-15
-2% -$4.5K 0.1% 178
2022
Q1
$213K Hold
745
0.07% 207
2021
Q4
$206K Buy
+745
New +$189K 0.06% 226
2020
Q1
Sell
-2,222
Closed -$292K 169
2019
Q4
$292K Hold
2,222
0.13% 152
2019
Q3
$248K Hold
2,222
0.12% 158
2019
Q2
$246K Hold
2,222
0.11% 171
2019
Q1
$288K Sell
2,222
-28
-1% -$3.4K 0.14% 146
2018
Q4
$260K Hold
2,250
0.14% 153
2018
Q3
$241K Buy
+2,250
New +$225K 0.11% 181
2018
Q1
Sell
-2,560
Closed -$216K 199
2017
Q4
$216K Hold
2,560
0.11% 189
2017
Q3
$219K Hold
2,560
0.11% 181
2017
Q2
$211K Sell
2,560
-150
-6% -$12.2K 0.11% 197
2017
Q1
$228K Buy
+2,710
New +$217K 0.12% 183

Other funds holding LLY

Holderness Investments Company's LLY Position: Q1 2026 in Review

Holderness Investments Company increased its Eli Lilly (LLY) stake by 32% in Q1 2026, buying an estimated $414K and bringing the position to 1,702 shares worth $1.57M. The position accounts for 0.31% of the portfolio, ranked #75.

Holderness Investments Company first reported a position in LLY in Q1 2017 and has held it in 28 quarters since. The position peaked at $2.05M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Holderness Investments Company held 1,702 shares of Eli Lilly worth $1.57M as of Q1 2026.
  • Holderness Investments Company bought 408 Eli Lilly shares in Q1 2026, an estimated $414K.
  • Eli Lilly made up 0.31% of Holderness Investments Company's portfolio in Q1 2026, its #75 holding.
  • Holderness Investments Company first reported a position in Eli Lilly in Q1 2017 and has held it in 28 quarters since.
  • Holderness Investments Company's Eli Lilly position peaked at $2.05M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Holderness Investments Company's 13F filing for Q1 2026, filed 12 May 2026.